MEK Inhibitors and NF1-Associated Tumors: Molecular Mechanisms and Targeted Approaches Published 2021-07-15 Download video MP4 360p Download video MP4 720p Recommendations 47:22 Cancer Risk in NF1 17:18 Low Sodium and How to Prevent Osmotic Demyelination Syndrome 06:31 Dr. Alex Adjei Explains MEK Inhibitors 1:08:54 Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheimer’s Disease 03:47 NF1 versus NF2 26:55 What is Lumbar Stenosis? Symptoms, Causes & Benefits of Ultrasonic Technology 53:54 25. Individual Differences 04:26 Neurofibromatosis no laughing matter 28:59 Navigating the Rapidly Evolving Landscape of Glomerular Kidney Disease Management 1:12:51 #AlzheimersDisease (#AD) updates led by Drs. McConathy & Rabinovici - bit.ly/ADPET24Y 57:26 Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH? 46:09 NF Summit 2022: Selumetinib - Clinical Trial Success Story 20:16 Fruits & vegetables — everything you need to know [AMA 36 Sneak Peek] | Peter Attia, M.D. 05:45 Neurofibromatosis, Causes, Signs and Symptoms, Diagnosis and Treatment. 05:24 How Neurofibromatosis Type 1 and Type 2 is caused | NF 1 & NF 2 1:22:59 Interdisciplinary Approaches to IMID Management: Addressing Shared Pathophysiology With JAKis 1:01:10 Advancing Therapies for Neurofibromatosis Type 1 (NF1): Lessons Learned from Every Patient 59:35 Stories Behind the Science in NCFBE: Disease Burden, Early Diagnosis, and New Management Options 03:03 The Johns Hopkins Comprehensive Neurofibromatosis Center 04:26 Adult Stem Cell Success - CIDP: Bryan Hinkle Similar videos 59:51 Application of New WHO Classification, CNS Tumors & Targeted Treatment Approaches in Neuro-Oncology 04:05 Treatment of NF1 With PNs: MEK Inhibition 06:10 Inhibition of MEK to Treat Cancer: Focus on Melanoma 08:47 BRAF/MEK Inhibitors in Metastatic Melanoma 01:34 2021 Clinical Research Forum Top 10| Selumetinib in Children with Inoperable Plexiform Neurofibromas 02:09 Appeal for funding MEK Inhibitor Research 02:20 Combination Strategies: MEK Inhibition and Immunotherapy in GIST 27:18 NF Forum 2015: Basic update on types of drugs in clinical trials for NF1 and NF2 42:29 Neurofibromatosis Type 2 - Dr. Charles Yates 1:31:21 Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas 2:02:00 NIH Demystifying Medicine: Neurofibromatosis Type 1 Tumors: Natural History To Precision Therapy 1:53:00 NF Forum 2020: NF1 Clinical Research Update 1:08:37 2021 Hack4Rare Introductory Webinar: Neurofibromatosis (NF) 1:03:16 Defining the Spectrum of Resistance to be Targeted Anti-Cancer Therapeutics 1:38:36 Demystifying Medicine 2015 - Ras: a Cancer Mechanism and Target 01:35 Detecting molecular features of infiltrative tumor cells linked to glioblastoma recurrence 1:09:22 Webinar: Everything you need to know about the TiNT MEK Inhibitor Clinical Trial 26:40 Dr Jim Whittle, presenting: Selumetinib More results